Literature DB >> 30272352

TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer.

Wenting He1, Dachuan Zhang2, Xiaodong Li3, Jun Wu3, Xuanxuan Yang3, Qi Wang3, Wenbin Lu4, Jingting Jiang5, Changping Wu3.   

Abstract

The aberrant expression of long non‑coding RNAs (lncRNAs) has been confirmed to play a pivotal role in tumor initiation and development. LncRNAs can interact with microRNAs (miRNAs) as competing endogenous RNAs (ceRNAs) to regulate the expression of target genes in various cancers. In the present study, the authors investigated the functions of lncRNAs as ceRNAs in gastric cancer (GC) and their implications for the prognosis. The RNA sequencing profiles of 372 tumor samples and 32 adjacent non‑tumor gastric samples were downloaded from The Cancer Genome Atlas (TCGA) database. The differential expression of RNAs was identified using the 'edgeR' package in R language software. Survival analysis was estimated based on Kaplan‑Meier curves. The Gene Ontology biological processes and the Kyoto Encyclopedia of Genes and Genomes pathways were analyzed for differentially expressed mRNAs. Finally, a total of 999 lncRNAs, 137 miRNAs and 1629 mRNAs were identified as differentially expressed (DE) in GC with log fold change (FC) thresholds >2 and adjusted P‑values <0.01. A ceRNA network was constructed with 65 DElncRNAs, nine DEmiRNAs and 24 DEmRNAs. Of the 65 DElncRNAs in the ceRNA network, nine were identified to be significantly associated with overall survival (P<0.05). A total of four DElncRNAs from the ceRNA network were validated by reverse transcription‑quantitative polymerase chain reaction and revealed to be associated with tumorigenesis and/or progression. In conclusion, the results of the present study provide information on the role of the ceRNA network in GC. These identified novel lncRNAs are potential candidate biomarkers and require further studies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30272352     DOI: 10.3892/or.2018.6720

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis.

Authors:  Mengxin Lin; Meifang Xu; Zongbin Xu; Zongqi Weng; Bingqiang Lin; Yanqin Lan; Qing Liu; Xiaoyan Lin; Jie Pan
Journal:  Hum Cell       Date:  2021-04-06       Impact factor: 4.174

2.  Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma.

Authors:  Junyu Long; Yi Bai; Xiaobo Yang; Jianzhen Lin; Xu Yang; Dongxu Wang; Li He; Yongchang Zheng; Haitao Zhao
Journal:  Cancer Cell Int       Date:  2019-04-11       Impact factor: 5.722

3.  MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis.

Authors:  Zhengmao Lu; Tianhang Luo; Tao Pang; Zongxin Du; Xiaoyi Yin; Hangtian Cui; Guoen Fang; Xuchao Xue
Journal:  Open Biol       Date:  2019-09-04       Impact factor: 6.411

4.  Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer.

Authors:  Hongda Pan; Chunmiao Guo; Jingxin Pan; Dongwei Guo; Shibo Song; Ye Zhou; Dazhi Xu
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

5.  Differentially expressed long noncoding RNAs and regulatory mechanism of LINC02407 in human gastric adenocarcinoma.

Authors:  Li-Li Zhou; Yan Jiao; Hong-Mei Chen; Li-Hua Kang; Qi Yang; Jing Li; Meng Guan; Ge Zhu; Fei-Qi Liu; Shuang Wang; Xue Bai; Yan-Qiu Song
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.